dm+d

Unassigned

New Medicines

Radiation-induced oral mucositis

Information

New molecular entity
Galera Therapeutics
Galera Therapeutics

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

First-in-class, small-molecule that mimics the activity of the superoxide dismutase enzyme family
97% of all patients receiving radiotherapy (with or without chemotherapy) for head and neck cancers will suffer from some degree of OM [1].
Radiation-induced oral mucositis
Intravenous infusion